OssDsign AB
STO:OSSD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
OssDsign AB
Accounts Receivables
OssDsign AB
Accounts Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Accounts Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
O
|
OssDsign AB
STO:OSSD
|
Accounts Receivables
kr26.1m
|
CAGR 3-Years
25%
|
CAGR 5-Years
33%
|
CAGR 10-Years
N/A
|
|
|
Xvivo Perfusion AB
STO:XVIVO
|
Accounts Receivables
kr101.3m
|
CAGR 3-Years
2%
|
CAGR 5-Years
20%
|
CAGR 10-Years
18%
|
|
|
D
|
Doxa AB
STO:DOXA
|
Accounts Receivables
kr4m
|
CAGR 3-Years
30%
|
CAGR 5-Years
19%
|
CAGR 10-Years
5%
|
|
|
Bactiguard Holding AB
STO:BACTI B
|
Accounts Receivables
kr35.8m
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
V
|
Vimian Group AB
STO:VIMIAN
|
Accounts Receivables
€57.3m
|
CAGR 3-Years
12%
|
CAGR 5-Years
21%
|
CAGR 10-Years
N/A
|
|
|
S
|
S2Medical AB (publ)
STO:S2M
|
Accounts Receivables
kr695k
|
CAGR 3-Years
-17%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
OssDsign AB
Glance View
OssDsign AB is a holding company, which designs, manufactures, and sells implants and material technology for bone regeneration. The company is headquartered in Uppsala, Uppsala. The company went IPO on 2019-05-24. The company aims at developing implantable products that respond to clinical challenges, with focus on bone healing. Its primary focus is skull surgery. The firm uses design solutions, material compositions and manufacturing processes mainly based on proprietary bioceramic technologies. The bioceramics it uses integrate with tissues and support bone ingrowth. OssDsign AB's main product is Craniomosaic, an implant for the repair of skull defects (cranioplasty). Along with it, the Company develops bioceramic implants for facial bone augmentation. The firm's customers include neurosurgeons, craniofacial and maxillofacial surgeons.
See Also
What is OssDsign AB's Accounts Receivables?
Accounts Receivables
26.1m
SEK
Based on the financial report for Dec 31, 2025, OssDsign AB's Accounts Receivables amounts to 26.1m SEK.
What is OssDsign AB's Accounts Receivables growth rate?
Accounts Receivables CAGR 5Y
33%
Over the last year, the Accounts Receivables growth was 2%. The average annual Accounts Receivables growth rates for OssDsign AB have been 25% over the past three years , 33% over the past five years .
